FDA Drug Application (020033) for LOTENSIN HCT by US PHARMS HOLDINGS I

Back to FDA Applications sponsored by US PHARMS HOLDINGS I

Application Number020033
Product Number001
FormTABLET;ORAL
Dosage5MG;6.25MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameLOTENSIN HCT
Active IngredientBENAZEPRIL HYDROCHLORIDE; HYDROCHLOROTHIAZIDE

Active IngredientCount
List of drugs with Active Ingredient BENAZEPRIL HYDROCHLORIDE8
List of drugs with Active Ingredient HYDROCHLOROTHIAZIDE122


Back to FDA Applications sponsored by US PHARMS HOLDINGS I